Cargando…
Cardiovascular clinical trials in the era of a pandemic
COVID‐19 has reached pandemic levels in March 2020 and impacted public health with unpredictable consequences.(1, 2) The conduct of clinical research in areas unrelated to COVID‐19 has been disrupted and will be further affected. Researchers, trial participants and study personnel have to overcome c...
Autores principales: | Siontis, George CM, Sweda, Romy, Windecker, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763388/ https://www.ncbi.nlm.nih.gov/pubmed/32993467 http://dx.doi.org/10.1161/JAHA.120.018288 |
Ejemplares similares
-
Antidepressant treatment in patients following acute coronary syndromes: a systematic review and Bayesian meta‐analysis
por: Sweda, Romy, et al.
Publicado: (2020) -
Estimating the sample size of sham-controlled randomized controlled trials using existing evidence
por: Siontis, George C.M., et al.
Publicado: (2022) -
Invasive electrophysiological testing to predict and guide permanent pacemaker implantation after transcatheter aortic valve implantation: A meta-analysis
por: Siontis, Konstantinos C., et al.
Publicado: (2022) -
Development and validation pathways of artificial intelligence tools evaluated in randomised clinical trials
por: Siontis, George C M, et al.
Publicado: (2021) -
Evaluation of Cumulative Meta-analysis of Rare Events as a Tool for Clinical Trials Safety Monitoring
por: Siontis, George C. M., et al.
Publicado: (2020)